Key Points
- Director Daniel Sajkowski sold 20,000 shares on April 1 at an average price of $12.55 for $251,000, reducing his position by 14.09% to 121,959 shares (about $1.53M).
- Calumet beat Q4 EPS (GAAP loss $0.43 vs. consensus $0.67) and reported improved FY2025 results — Adjusted EBITDA of $293.3M, $222M of recourse debt reduction, roughly $100M of cost savings, and a Montana Renewables expansion on track for Q2 2026.
- Market view and risks: consensus rating is "Hold" with an average price target of $22.83 and a $2.62B market cap, while rising short interest (~8.4% of the float) and mixed analyst opinions signal potential volatility.
Calumet, Inc. (NASDAQ:CLMT - Get Free Report) Director Daniel Sajkowski sold 2,000 shares of the business's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $15.77, for a total value of $31,540.00. Following the transaction, the director directly owned 82,237 shares of the company's stock, valued at $1,296,877.49. This represents a 2.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Calumet Trading Down 6.6%
CLMT traded down $2.01 during midday trading on Friday, reaching $28.21. The company's stock had a trading volume of 131,011 shares, compared to its average volume of 1,367,579. The company has a fifty day simple moving average of $22.92 and a 200 day simple moving average of $19.82. The stock has a market cap of $2.45 billion, a P/E ratio of -65.58 and a beta of 1.24. Calumet, Inc. has a twelve month low of $7.68 and a twelve month high of $30.35.
Calumet (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share for the quarter, beating the consensus estimate of ($0.67) by $0.24. The business had revenue of ($3,098.50) million during the quarter, compared to the consensus estimate of $1.04 billion. During the same period in the prior year, the company posted ($0.47) earnings per share. The firm's revenue was up 9.4% compared to the same quarter last year. Sell-side analysts expect that Calumet, Inc. will post -3.02 earnings per share for the current year.
Analysts Set New Price Targets
CLMT has been the topic of a number of recent research reports. Weiss Ratings reissued a "sell (d-)" rating on shares of Calumet in a research report on Monday, December 29th. The Goldman Sachs Group lifted their price objective on Calumet from $20.00 to $24.00 and gave the stock a "buy" rating in a report on Friday, January 30th. TD Cowen restated a "hold" rating on shares of Calumet in a research report on Thursday, January 29th. UBS Group reaffirmed a "neutral" rating and issued a $26.00 target price on shares of Calumet in a research report on Friday, February 13th. Finally, Wall Street Zen lowered shares of Calumet from a "buy" rating to a "hold" rating in a report on Sunday, December 14th. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $22.83.
Check Out Our Latest Research Report on CLMT
Institutional Trading of Calumet
Several institutional investors have recently bought and sold shares of CLMT. ELCO Management Co. LLC raised its stake in Calumet by 31.9% during the second quarter. ELCO Management Co. LLC now owns 43,060 shares of the oil and gas company's stock worth $678,000 after acquiring an additional 10,402 shares in the last quarter. Premier Path Wealth Partners LLC boosted its stake in shares of Calumet by 11.4% in the 2nd quarter. Premier Path Wealth Partners LLC now owns 12,853 shares of the oil and gas company's stock valued at $202,000 after purchasing an additional 1,320 shares in the last quarter. Amalgamated Bank bought a new stake in shares of Calumet in the 2nd quarter worth about $37,000. SP Asset Management LLC acquired a new stake in shares of Calumet during the 2nd quarter worth about $205,000. Finally, ProShare Advisors LLC bought a new position in Calumet during the 2nd quarter valued at about $223,000. Institutional investors and hedge funds own 34.41% of the company's stock.
More Calumet News
Here are the key news stories impacting Calumet this week:
- Positive Sentiment: Q4 EPS beat — Calumet reported GAAP EPS of ($0.43) vs. consensus ($0.67), reducing downside surprise and supporting near‑term sentiment. Read More.
- Positive Sentiment: FY2025 operational and financial improvements — management reported Adjusted EBITDA with tax attributes of $293.3M, ~$222M of recourse debt reduction, roughly $100M in cost savings driving free cash flow, and a planned Montana Renewables expansion on track for Q2 2026; these items de‑risk the business and support medium‑term valuation. Read More.
- Neutral Sentiment: Analyst and preview coverage mixed — pre‑earnings pieces and recent analyst notes (Goldman raised its PT; other firms varied between buy/hold/sell) helped set expectations ahead of the release but did not provide new guidance. Read More.
- Negative Sentiment: Insider selling — Director Daniel J. Sajkowski disclosed multiple recent sales (several 20k‑share tranches), materially trimming his stake; visible insider selling can be perceived negatively even if for personal/liquidity reasons. Read More.
- Negative Sentiment: Rising short interest — short positions rose materially in February to roughly 6.97M shares (~8.4% of shares), with a ~4.4 days‑to‑cover figure, increasing the risk of continued selling pressure or intraday volatility. Read More.
About Calumet
(
Get Free Report)
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet's product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
